Press release
Decentralized Clinical Trials Market Accelerates Amid Shift to Remote Monitoring Technologies 2025-2033 | ICON plc, Parexel International Corporation, Laboratory Corporation of America Holdings
Decentralized Clinical Trials Market
The latest Decentralized Clinical Trials market research report from DataM Intelligence delivers a comprehensive analysis of the global Decentralized Clinical TrialsMarket landscape, highlighting emerging trends, market size, competitive dynamics, and key growth drivers. By leveraging advanced analytics, technology trend mapping, and regulatory assessment, the report highlights emerging growth drivers, evolving care models, and investment opportunities. It equips stakeholders with strategic intelligence essential for navigating the complex healthcare ecosystem from clinical innovation to operational efficiency across the forecast period 2024-2031.
Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access):
https://www.datamintelligence.com/download-sample/decentralized-clinical-trials-market?ophp
Decentralized Clinical Trials (DCTs) are conducted remotely using digital tools such as apps and wearable sensors, allowing participants to take part from home. The market is expanding rapidly as sponsors seek more inclusive, cost-effective, and patient-centric trial models.
Comprehensive Insight into Decentralized Clinical Trials Market Landscape and Growth Trends:
Top Companies
ICON plc, Parexel International Corporation, Laboratory Corporation of America Holdings, Medpace, Inc., Science 37, THREAD, Inc., Curebase, Castor, IQVIA Inc., and Medable Inc., among others.
Emerging Players
The emerging players in the decentralized clinical trials market include Veeva Systems Inc., PRAXIS, Advarra, The Emmes Company, LLC, and Syneos Health, among others.
Important Mergers, Acquisitions, and Market Shifts:
In May 2025, ABM Respiratory Care, an innovator in respiratory therapy solutions, announced the initiation of a multi-center home care study in collaboration with Delve Health, a trailblazer in decentralized clinical trial technology, to evaluate the impact of its BiWaze Clear System in patients living with bronchiectasis. The study will assess how the BiWaze Clear System affects respiratory health over six months.
In October 2024, Adaptive Research, a clinical trial site organization dedicated to democratizing clinical trials, announced its participation in a groundbreaking decentralized study for Parkinson's Disease sponsored by PhotoPharmics Inc. California Movement Disorders Center, part of Adaptive Research's network, will serve as a site for PhotoPharmics' LIGHT-PD trial, testing the efficacy of Celeste Specialized Phototherapy in treating Parkinson's symptoms.
In August 2024, Walgreens and the Biomedical Advanced Research and Development Authority (BARDA) announced a strategic partnership to increase innovation in decentralized clinical trials as part of the Decentralized Clinical Operations for Healthcare and Research (D-COHRe) program. The program is designed to strengthen U.S. decentralized clinical research capabilities to support the development of U.S. Food and Drug Administration (FDA)-regulated products, enhance clinical innovation to execute more efficient and relevant clinical research, and evaluate other medical countermeasures in real-world environments that may be used in a public health emergency.
Market Drivers:
A shift toward patient-centric models, cost-efficient operations, and remote monitoring capabilities is pushing the growth of decentralized clinical trial solutions.
Decentralized Clinical Trials Market Segments:
By Study Type (Interventional Trials, Observational Trials, Expanded Access Trials, Others)
By Component (Software Solutions, Hardware Solutions)
By Therapeutic Area ( Oncology, Cardiovascular Diseases, Infectious Diseases, Respiratory Diseases, Neurology, Rare Diseases, Metabolic Disorders, Others)
By End-User ( Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes, Others)
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/decentralized-clinical-trials-market?ophp
Methodology and Scope:
This Decentralized Clinical Trials Market report is developed using a robust research methodology that combines primary interviews, insights from industry experts, and verified secondary sources such as company filings, trade journals, and trusted databases. It follows a bottom-up and top-down approach to ensure data accuracy through triangulation. The scope of the report covers current market trends, growth potential, and strategic developments across global and regional markets.
Regional Overview for Decentralized Clinical Trials Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Looking For Exclusive Full Report? Get it here: https://www.datamintelligence.com/buy-now-page?report=decentralized-clinical-trials-market?ophp
The Report Includes:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Go-to-market Strategy.
➡ Neutral perspective on the market performance.
➡ Customized regional/country reports as per request and country level analysis.
➡ Potential & niche segments and regions exhibiting promising growth covered.
People Also Ask:
➠ What are the global sales, production, consumption, imports, and exports in the Decentralized Clinical Trials market?
➠ Who are the top manufacturers, and what are their capacity, production, sales, pricing, and revenue stats?
➠ What key opportunities and challenges do vendors face in the Decentralized Clinical Trials industry?
➠ Which product types, applications, or end-users are driving market growth, and what is their market share?
➠ What are the major growth drivers and restraints of the Decentralized Clinical Trials market?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Decentralized Clinical Trials Market Accelerates Amid Shift to Remote Monitoring Technologies 2025-2033 | ICON plc, Parexel International Corporation, Laboratory Corporation of America Holdings here
News-ID: 4089902 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
United States Allergy Immunotherapies Market 2025 | Growth Drivers, Trends & Mar …
Market Size and Growth
The "Global Allergy Immunotherapies Market" is predicted to reach at a high CAGR of 10.4% during the forecast period (2022-2029)
Key Development:
United States: Recent Industry Developments
✅ In September 2025, Sanofi expanded its allergy immunotherapy portfolio by acquiring Ayvakit and early-stage immunology assets for USD 9.1 billion, enhancing its position in severe allergic conditions.
✅ In June 2025, BioVaxys Technology Corp. launched a private placement to raise USD 1.2-1.6…
United States Cancer CDK Inhibitors Market 2025 | Growth Drivers, Key Players & …
Market Size and Growth
Global Cancer CDK Inhibitors Market reached US$ 9.3 billion in 2023 and is expected to reach US$ 13.8 billion by 2031, growing at a CAGR of 5.2% during the forecast period 2024-2031.
Key Development:
United States: Recent Industry Developments
✅ In June 2025, Gilead Sciences and Kymera Therapeutics entered into an exclusive option and license agreement to develop novel oral molecular glue CDK2 degraders. This collaboration aims to accelerate the…
United States Urinalysis Testing Products Market 2025 | Growth Drivers, Trends & …
Market Size and Growth
Urinalysis Testing Products market is estimated to reach at a high CAGR of 7.3 % during the forecast period (2023-2030).
Key Development:
United States: Recent Industry Developments
✅ In April 2025, H.U. Group Holdings, Inc. and its subsidiary Fujirebio Holdings, Inc. received a $4.5 million grant from the Global Health Innovative Technology (GHIT) Fund to develop an ultrasensitive point-of-care urine test for tuberculosis.
Japan: Recent Industry Developments
✅ In June 2025,…
Global Green Hydrogen Market Projected to Grow at 20.9% CAGR Through 2031, Drive …
The Global Green Hydrogen Market is expected to grow at a CAGR of 20.9% during the forecast period (2024-2031), according to DataM Intelligence.
United States: Recent Industry Developments
✅ In September 2025, The Department of Energy announced $8 billion in funding for regional green hydrogen hubs under the Infrastructure Investment and Jobs Act.
✅ In August 2025, Plug Power commissioned the largest green hydrogen production facility in North America…
More Releases for Trials
Clinical Trials Management System Market Trends: How Decentralized Clinical Tria …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Clinical Trials Management System Market Size, Share & Trends Analysis Report By Solution Type (Enterprise and Site based), By Delivery Mode (Web & Cloud-based, On-premise), By Component (Software, Services), By End-user (Pharmaceutical and Biotechnology Firms, Medical Device Firms, CROs)- Market Outlook And Industry Analysis 2031"
The global Clinical Trials Management System market is estimated to reach…
Brazil Clinical Trials Market ANVISA Brazil Guidelines Brazil Clinical Trials Re …
Brazil Cancer Drugs Clinical Trials Insight 2024 Report Offering:
• Brazil Clinical Trials Market Opportunity 2024 and 2030 (In US$ Billion)
• Clinical Trials Regulatory Framework In Brazil
• Total Number of Cancer Drugs In Clinical Trials In Brazil
• Total Number Of Cancer Drugs Approved In Brazil
• 400 Pages Clinical Trials Insight On All Cancer Drugs In Clinical Trials By Company, Indication and Phase
• 80 Pages Clinical Insight On All Cancer Drugs Approved in Market By Company and Indication
• Insight…
Clinical Trials Management System Market Clinical Trials Management System Marke …
InsightAce Analytic announces the release of a market assessment report on the "Global Clinical Trials Management System Market Size, Share & Trends Analysis Report By Solution Type (Enterprise and Site based), By Delivery Mode (Web & Cloud-based, On-premise), By Component (Software, Services), By End-user (Pharmaceutical and Biotechnology Firms, Medical Device Firms, CROs)- Market Outlook And Industry Analysis 2031.
The global Clinical Trials Management System market is estimated to reach over USD…
Revolutionizing Clinical Trials: The Evolution of eCOA, eSource, and the Clinica …
The global eCOA, eSource & clinical trials market is valued at US$ 48 billion in 2023 and is expected to reach a market size of US$ 104 billion by the end of 2033, expanding rapidly at a CAGR of 8% over the next ten years. Worldwide demand for eCOA (electronic clinical outcome assessment) solutions is predicted to rise at a CAGR of 8.2% over the forecast period.
In the dynamic landscape…
Virtual Clinical Trials Market - Bridging the Gap: Virtual Clinical Trials Revol …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Virtual Clinical Trials Market.
Virtual Clinical Trials Market: https://www.growthplusreports.com/report/virtual-clinical-trials-market/9106
The Virtual Clinical Trials Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the…
Clinical Trials Market: Coronavirus Pandemic Pushes Sponsors, Patients to Adopt …
Clinical trials Market: Introduction
According to the report, the global clinical trials market was valued over US$ 46.7 Bn in 2019 and is projected to expand at a CAGR of ~5% from 2020 to 2030. High prevalence and increase in incidence rate of chronic diseases, and rise in R&D activities in biotechnology & pharmaceuticals industries are anticipated to drive the global clinical trials market from 2020 to 2030. North America is projected to…
